# HeartBeam (BEAT) — News

BEAT · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/beat/news

## Recent headlines

- [Heartbeam joins European exit-CVD research consortium to advance at-home ECG monitoring for early detection of acute coronary syndrome (ACS) in high-risk patients](https://www.ainvest.com/news/heartbeam-joins-european-exit-cvd-research-consortium-advance-home-ecg-monitoring-early-detection-acute-coronary-syndrome-acs-high-risk-patients-2610) — AInvest Wire, Oct 15, 2026
- [CEAT 2Q other income 50M rupees, +25% y/y](https://www.ainvest.com/news/ceat-2q-income-50m-rupees-25-2610) — AInvest Wire, Oct 14, 2026
- [CEAT 2Q rev. 47.6B rupees, est. 46.49B rupees](https://www.ainvest.com/news/ceat-2q-rev-47-6b-rupees-est-46-49b-rupees-2610) — AInvest Wire, Oct 14, 2026
- [CEAT 2Q net income 1.12B rupees, -40% y/y](https://www.ainvest.com/news/ceat-2q-net-income-1-12b-rupees-40-2610) — AInvest Wire, Oct 14, 2026
- [Heartbeam receives FDA breakthrough device designation for heart attack assessment](https://www.ainvest.com/news/heartbeam-receives-fda-breakthrough-device-designation-heart-attack-assessment-2610) — AInvest Wire, Oct 5, 2026
  Heartbeam, Inc. has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its non-invasive heart attack assessment technology [1]. This designation is intended to expedite the development and regulatory review of medical devices that offer significant…

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).